PRISM (Pictorial Representation of Illness and Self Measure)- a novel visual method to assess the global burden of illness in patients with systemic lupus erythematosus.

Abstract:

OBJECTIVE:For patients with chronic illnesses the global burden of illness is a crucial health measure hitherto neglected in research studies and clinical practice. We tested the application and validity of PRISM (Pictorial Representation of Illness and Self-Measure), a novel visual method for assessing the burden of illness, in patients with systemic lupus erythematosus (SLE). METHOD:PRISM was applied in a cross sectional sample of 60 patients with SLE. Correlations were assessed between a quantitative measure derived from PRISM (Self-Illness Separation-SIS) and sociodemographic factors, measures of disease activity, damage, physical and psychological disability variables, as well as coping resources. RESULTS:The PRISM task was understood by all but one patient, and was in every instance completed in less than 3 minutes. SIS correlated with SF-36 physical health, coping resources as assessed by Sense of Coherence (SOC), and age, but not with disease activity or damage. In multiple regression analyses, independent contributions to SIS were observed for SF-36 physical component scale (contributing 12% of the variance). SOC (10%) and age (14%). CONCLUSION:PRISM is a new non-verbal measure to assess burden of illness. As in previous studies, PRISM was well accepted and understood by patients with SLE, quick to complete, and yielded meaningful information consistent with that in earlier research work.

journal_name

Lupus

journal_title

Lupus

authors

Büchi S,Villiger P,Kauer Y,Klaghofer R,Sensky T,Stoll T

doi

10.1191/096120300678828479

subject

Has Abstract

pub_date

2000-01-01 00:00:00

pages

368-73

issue

5

eissn

0961-2033

issn

1477-0962

journal_volume

9

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Vulvar intraepithelial neoplasia in a young woman with systemic lupus erythematosus: a case report.

    abstract::Diagnosing vulvar intraepithelial neoplasia in a young woman presenting mainly with skin manifestations of lupus and with no other risk factors is a major challenge. The case of a 27-year-old woman with systemic lupus erythematosus and vulvar intraepithelial neoplasia is described. Although progression of vulvar intra...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345742

    authors: Stepanić V,Corusić A,Matković V,Sentić M,Bosnić D,Mahovlić V

    更新日期:2010-01-01 00:00:00

  • Skeletal muscle lymphocytic vasculitis in systemic lupus erythematosus: relation to disease activity.

    abstract::Lymphocytic vasculitis (LV) characterises systemic lupus erythematosus (SLE) and this potentially reversible lesion, which may be subclinical, may imply overt systemic disease activity. Needle quadriceps muscle biopsy was performed in 26 unselected patients with SLE and the presence of LV in these muscle specimens was...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339500400213

    authors: Lim KL,Lowe J,Powell RJ

    更新日期:1995-04-01 00:00:00

  • Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

    abstract::In examining reasons for premature atherosclerosis in systemic lupus erythematosus (SLE), we previously reported low levels of the cholesterol transport protein apolipoprotein A1 (apoA1) in these patients, and specific antibodies to purified apoA1 were identified in the sera of 5 out of 30 lupus patients. The current ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920262

    authors: Dinu AR,Merrill JT,Shen C,Antonov IV,Myones BL,Lahita RG

    更新日期:1998-01-01 00:00:00

  • Aberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus.

    abstract::Integrin very late antigen-4 (VLA4) is induced during inflammation and can regulate monocyte migration. It has been implicated in atherogenesis, a significant concern in systemic lupus erythematosus (SLE). The aim of this study was to define VLA4 expression in SLE monocytes. Flow cytometry, reverse transcription polym...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313475691

    authors: Rahimi H,Maurer K,Song L,Akhter E,Petri M,Sullivan KE

    更新日期:2013-03-01 00:00:00

  • The CD11b-integrin (ITGAM) and systemic lupus erythematosus.

    abstract::Variations at the ITGAM gene, which encodes for the CD11b chain of the Mac-1 (alphaMbeta2; CD11b/CD18; complement receptor-3) integrin, is one of the strongest genetic risk factors for systemic lupus erythematosus (SLE). More specifically, a genetic variant (rs1143679) which results in an arginine to histidine substit...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313491851

    authors: Fagerholm SC,MacPherson M,James MJ,Sevier-Guy C,Lau CS

    更新日期:2013-06-01 00:00:00

  • Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.

    abstract::Legionnaire's disease (LD) is most commonly caused by Legionella pneumophila (L. pneumophila). In immunocompromised patients LD can cause necrosis of the lung parenchyma with abscess formation and cavitation. Systemic lupus erythematosus (SLE) is an autoimmune disorder with features of both primary and secondary immun...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203321990102

    authors: Khokher W,Kesireddy N,Adunse J,Mudiyanselage PH,Iftikhar S,Assaly R

    更新日期:2021-01-26 00:00:00

  • Massive ovarian haemorrhage complicating oral anticoagulation in the antiphospholipid syndrome: a report of three cases.

    abstract::We report three cases of severe haemorrhagic rupture of luteal ovarian cyst requiring surgical haemostasis in young women treated with long-term oral anticoagulation for antiphospholipid syndrome (APS) who used no contraception. At the time of bleeding, the international normalized ratios were 3.78, 4.24, and 7.11. An...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339900800614

    authors: Crétel E,Cacoub P,Huong DL,Gompel A,Amoura Z,Piette JC

    更新日期:1999-01-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria.

    abstract::In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) group published a new set of classification criteria for systemic lupus erythematosus (SLE). Studies applying these criteria to real-life scenarios have found either equal or greater sensitivity and equal or lower specificity to the 1997 ACR class...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316657434

    authors: Ungprasert P,Sagar V,Crowson CS,Amin S,Makol A,Ernste FC,Osborn TG,Moder KG,Niewold TB,Maradit-Kremers H,Ramsey-Goldman R,Chowdhary VR

    更新日期:2017-03-01 00:00:00

  • Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.

    abstract::Objectives We analyzed the clinical follow-up results of 88 lupus nephritis patients to find prognostic factors for the development of chronic kidney disease in ethnically homogeneous Korean patients with biopsy-proven lupus nephritis. Methods Sociodemographic, clinical, laboratory, and treatment-related data at the t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317694257

    authors: Park DJ,Kang JH,Lee JW,Lee KE,Kim TJ,Park YW,Lee JS,Choi YD,Lee SS

    更新日期:2017-10-01 00:00:00

  • Primary antiphospholipid antibody syndrome presenting with adrenal insufficiency in a child: case report and review of literature.

    abstract::A 7-year-old boy presented with adrenal insufficiency. He subsequently developed venous thrombosis in the limbs and was diagnosed with primary antiphospholipid syndrome (PAPS) based on clinical and laboratory parameters. Both adrenals were normal on imaging. He required thrombolysis and anticoagulation. The progressiv...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203310397965

    authors: Bhakhri BK,Katewa S,Sharma R,Mahajan S

    更新日期:2011-10-01 00:00:00

  • Maternal deaths in women with lupus nephritis: a review of published evidence.

    abstract:BACKGROUND AND OBJECTIVES:Pregnancies in women with systemic lupus erythematosus (SLE) and lupus nephritis are considered high-risk due to high rates of maternal and fetal complications. However, there has not been a formal analysis addressing the issue of maternal deaths in these women. The aim of this study was to pe...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311434939

    authors: Ritchie J,Smyth A,Tower C,Helbert M,Venning M,Garovic V

    更新日期:2012-04-01 00:00:00

  • A cross-sectional study of anti-DNA antibodies in the serum and IgG and IgM fraction of healthy individuals, patients with systemic lupus erythematosus and their relatives.

    abstract::Sera from healthy individuals, relatives of lupus patients, and lupus patients with active disease and in remission were screened for IgG and IgM antibodies to ssDNA and dsDNA. The serum samples were also separated into IgG and IgM fractions which were screened for DNA reactivity at dilutions equivalent to those used ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500604

    authors: Williams WM,Isenberg DA

    更新日期:1996-12-01 00:00:00

  • Revisiting the anticardiolipin test and its standardization.

    abstract::Although the importance of the anticardiolipin test in diagnosis of antiphospholipid syndrome (APS) is widely accepted, there remains much misunderstanding about the strengths and weaknesses of this assay. Several disorders result in formation of low levels of the antibody, hence the anticardiolipin test is not specif...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu202cr

    authors: Harris EN,Pierangeli SS

    更新日期:2002-01-01 00:00:00

  • Sulpha allergy in lupus patients: a clinical perspective.

    abstract::Systemic lupus erythematosus is a chronic, relapsing autoimmune disease that can affect multiple organ systems. An increased prevalence of drug allergy has been reported in lupus patients compared with the general population. Using a cohort of 417 lupus patients, we found a history of sulpha allergy in 27.3% of patien...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086640

    authors: Jeffries M,Bruner G,Glenn S,Sadanandan P,Carson CW,Harley JB,Sawalha AH

    更新日期:2008-03-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.

    abstract::Background Systemic lupus erythematosus (SLE) is an autoimmune disease marked by the disruption of the immune homeostasis. Patients exhibit a wide range of clinical manifestations, and environmental and genetic factors are involved in SLE pathogenesis. Evidence suggests that abnormalities in the cellular and molecular...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316678671

    authors: Glesse N,Vianna P,Paim LMG,Matte MCC,Aguiar AKK,Palhano PL,Monticielo OA,Brenol CV,Xavier RM,Chies JAB

    更新日期:2017-06-01 00:00:00

  • Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods study.

    abstract:OBJECTIVE:This study aimed to explore the experience and impact of fatigue in adults with primary antiphospholipid syndrome (pAPS). METHODS:This sequential, explanatory mixed-methods study enrolled adults with a six-month or more history of pAPS. Consenting participants completed the Functional Assessment of Chronic I...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320928421

    authors: Bearne LM,Bieles J,Georgopoulou S,Andrews J,Tully A,Stolarchuk-Prowting K,Williamson T,Suarez BS,Nel L,D'Cruz D,Lempp H

    更新日期:2020-07-01 00:00:00

  • Association of TNFSF4 rs1234315, rs2205960 polymorphisms and systemic lupus erythematosus susceptibility: a meta-analysis.

    abstract:BACKGROUND:The aim of this study was to explore the association between tumor necrosis factor superfamily number 4 (TNFSF4) rs1234315, rs2205960 polymorphisms and systemic lupus erythematosus (SLE) susceptibility. METHODS:A meta-analysis was performed on the association between rs1234315 and rs2205960 polymorphisms an...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203319862610

    authors: Wang JM,Yuan ZC,Huang AF,Xu WD

    更新日期:2019-09-01 00:00:00

  • Onset of autoimmune glomerulonephritis derived from the telomeric region of MRL-chromosome 1 is associated with the male sex hormone in mice.

    abstract::Female B6.MRLc1(82-100) congenic mice develop more severe autoimmune glomerulonephritis (AGN) than males. We assessed the effects of gonadectomy on the pathogenesis of AGN in these mice. One-month-old male and female mice were divided into sham-operated group (SG) and gonadectomized group (GG), and the pathological ch...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308098989

    authors: Ichii O,Konno A,Sasaki N,Endoh D,Hashimoto Y,Kon Y

    更新日期:2009-05-01 00:00:00

  • Immunizing patients with systemic lupus erythematosus: a review of effectiveness and safety.

    abstract::Concerns regarding the safety and efficacy of immunization in patients with SLE have persisted for over 60 years, despite the increased risk of infection in these patients. There are many anecdotal case reports of SLE induction or exacerbation following immunization, but overall, these events seem to be very rare. Evi...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203306069355

    authors: O'Neill SG,Isenberg DA

    更新日期:2006-01-01 00:00:00

  • Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

    abstract:OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic, multisystemic, immune-mediated disorder associated with a substantial hospitalization risk. As a comparatively rare disease, there is a sparsity of research examining the burden of hospital admission in the contemporary era. We aim to describe national trends ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319853357

    authors: Hannah J,Galloway J,Kaul A

    更新日期:2019-06-01 00:00:00

  • Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.

    abstract::Cyclophosphamide (CYC) is used in severe neuropsychiatric systemic lupus erythematosus (NPSLE), but long-term data regarding its efficacy and safety are lacking. We identified NPSLE cases who received CYC from two centres during the period 1999-2013 and had regular follow-up. General and neuropsychiatric outcome at la...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315622821

    authors: Fanouriakis A,Pamfil C,Sidiropoulos P,Damian L,Flestea A,Gusetu G,Rednic S,Bertsias G,Boumpas DT

    更新日期:2016-05-01 00:00:00

  • Anti-α-enolase antibody combined with β2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients.

    abstract:OBJECTIVE:Anti-α-enolase antibody (Ab) combined with β2 microglobulin (β2-MG) were investigated to predict the incidence of nephritis in systemic lupus erythematosus (SLE) patients. METHODS:Levels of serum anti-α-enolase Ab and urinary β2-MG were detected in 115 SLE patients, 29 SLE patients with nephritis and 70 heal...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319828822

    authors: Huang Y,Chen L,Chen K,Huang F,Feng Y,Xu Z,Wang W

    更新日期:2019-03-01 00:00:00

  • Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.

    abstract:OBJECTIVE:The objective of this paper is to assess the role of gender on survival rate and causes of death and organ damage in systemic lupus erythematosus (SLE) patients in China from 2009 to 2015. METHODS:We conducted a multicenter cohort study to analyze the differences in outcome data between male and female SLE p...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319839845

    authors: Zhang S,Ye Z,Li C,Li Z,Li X,Wu L,Liu S,Zuo X,Zhu P,Wang Z,Wang Y,Wang Z,Zhao J,Wang Q,Tian X,Li M,Zeng X

    更新日期:2019-04-01 00:00:00

  • Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

    abstract:OBJECTIVE:The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were co...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312470977

    authors: Iacobaeus E,Hopia L,Khademi M,Lundén M,Hammarin AL,Svenungsson E,Andersson M

    更新日期:2013-03-01 00:00:00

  • A case of drug-induced lupus erythematosus secondary to trimethoprim/sulfamethoxazole presenting with pleural effusions and pericardial tamponade.

    abstract::We report a case of drug-induced lupus erythematosus (DILE) secondary to trimethoprim/sulfamethoxazole (TMP/SMX) in a patient with underlying inflammatory bowel disease (IBD). The initial presentation was with febrile pleural and pericardial effusions followed by cardiac tamponade. The patient was treated with a short...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316657435

    authors: Jose A,Cramer AK,Davar K,Gutierrez G

    更新日期:2017-03-01 00:00:00

  • In vivo models of thrombosis for the antiphospholipid syndrome.

    abstract::Utilizing this unique animal model of thrombosis we demonstrated that human (IgG, IgM or IgA) polyclonal and monoclonal antiphospholipid antibodies derived from APS patients have a significant enhancing effect on thrombus formation. This effect is reversed by treatment of the mice with hydroxychloroquine (plaquenil). ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500524

    authors: Pierangeli SS,Harris EN

    更新日期:1996-10-01 00:00:00

  • Anti-carbamylated protein antibodies in systemic lupus erythematosus patients with articular involvement.

    abstract::Objective Several studies have evaluated the prevalence of rheumatoid factor (RF) and anti-citrullinated proteins antibodies (ACPA) in systemic lupus erythematosus (SLE) patients but no data are available on the anti-carbamylated proteins (anti-CarP), a new biomarker for rheumatoid arthritis (RA). We evaluated the ant...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317713141

    authors: Massaro L,Ceccarelli F,Colasanti T,Pendolino M,Perricone C,Cipriano E,Natalucci F,Capalbo G,Lucchetti R,Pecani A,Vomero M,Mancini R,Spinelli FR,Alessandri C,Valesini G,Conti F

    更新日期:2018-01-01 00:00:00

  • Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.

    abstract::We have explored the relationship between possible hemostatic changes and clinical manifestation of the systemic lupus erythematosus (SLE) as a function of greater or lesser disease activity according to Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) criteria. Endothelial injury and hypercoagulab...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319899478

    authors: Cicarini WB,Duarte RCF,Ferreira KS,Loures CMG,Consoli RV,Neiva CLS,de Pádua PM,Nunes FFC,Alves LCV,Reis EA,Moreira CC,Guimarães TMPD,de Toledo VPCP,Carvalho MDG

    更新日期:2020-02-01 00:00:00